MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes- Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer Therapies
Abstract
Authors
G.W. Frederix J.G. Van hasselt J.H. Schellens A.M. Hövels A.D. Huitema J.A. Raaijmakers J. Severens